MedPath

Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia

Recruiting
Conditions
Telangiectasia, Hereditary Hemorrhagic
Registration Number
NCT00230685
Lead Sponsor
Imperial College London
Brief Summary

This observational study is for individuals with Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations that are reviewed at the Hammersmith Hospital, London.

Detailed Description

The Hammersmith Hospital provides a clinical service for patients with Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations that is unique in the United Kingdom. Measurements obtained as part of standard clinical practice that has evolved since 1985 allow us to assess whether particular groups of individuals that we see are more prone to recognised complications such as strokes, brain abscesses, pregnancy related complications or pulmonary hypertension. We hypothesise that certain clinical characteristics will predict the susceptibility of individuals to particular complications.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
2000
Inclusion Criteria
  • Patients attending Hammersmith Hospital
Exclusion Criteria
  • None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Venous thromboemboli (VTE)Prospective

VTE of any origin

StrokeProspective

Ischaemic stroke attributable to PAVMs

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Respiratory Medicine, Hammersmith Hospital

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath